HOUSE 1350118th CongressReferred to the Subcommittee on Health.
Cameron’s Law
- Last Action
- 3/10/2023
Actions
- 2023-03-10Referred to the Subcommittee on Health.
- 2023-03-03Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2023-03-03Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2023-03-03Introduced in House
- 2023-03-03Introduced in House
CRS Summary
As of 2023-03-03 (00)
Cameron's Law
This bill increases the rate of the tax credit for clinical testing expenses for rare diseases or conditions from 25% to 50% (orphan drug tax credit).
The bill also requires the Centers for Disease Control and Prevention to complete a study to evaluate the feasibility of enhancing and expanding the infrastructure to track the epidemiology of rare diseases or conditions.
Cosponsors (1)
- Don Bacon (R-NE)
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.